Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|Golidocitinib||AZD 4205|AZD-4205|AZD4205||JAK1 Inhibitor 9||Golidocitinib (AZD4205) is a selective inhibitor of JAK1, which reduces downstream signaling and may lead to inhibition of cell proliferation and tumor growth (PMID: 32297743, NCI Thesaurus).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04105010||Phase II||Golidocitinib||Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)||Active, not recruiting||USA | AUS||2|